ArticleJournal of the Endocrine Society2026
Clinical profile, treatment practices, and complications in chronic hypoparathyroidism in a Middle Eastern cohort.
Article in Journal of the Endocrine Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Context: Hypoparathyroidism is a rare but clinically significant endocrine disorder with an unknown prevalence and complication burden in our region. Objective: This study aims to estimate the frequency of chronic hypoparathyroidism, assess its characteristics, and evaluate the current clinical practice of chronic postsurgical and idiopathic hypoparathyroidism in patients attending Dubai Hospital, UAE. It assesses biochemical profiles, physician monitoring practices, and their adherence to established guidelines. Methods: A retrospective observational study was conducted by reviewing medical records of all eligible patients. Results: A total of 65 patients with a mean age of 47.02 years were included, mostly female (76.9%) and diagnosed with postsurgical hypoparathyroidism (81.5%). Regular monitoring included calcium and vitamin D, but phosphate and creatinine were monitored less frequently. Patients were commonly prescribed high doses of calcium (median 2400 mg), with idiopathic cases requiring higher doses (mean 4200 mg). Monitoring for course and complications revealed that 55.4% of patients underwent renal imaging, 27.7% had brain imaging, 75.4% received electrocardiography (ECG) assessments, 35.4% had echocardiography, and 44.6% had documented ophthalmologic evaluations. Conclusion: This study provides the first epidemiological and demographic assessment of hypoparathyroidism in the UAE, highlighting both similarities and differences in frequency, revealing unique patient characteristics, treatment patterns, and monitoring practices. Compared to global trends, UAE patients demonstrated a higher calcium requirement and distinctive demographic patterns, including a younger mean age and a male predominance in idiopathic cases. Despite regular calcium and vitamin D monitoring, the study highlights suboptimal biochemical surveillance and complication screening, underscoring the need for improved adherence to clinical guidelines.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.